Key facts
- This page summarizes Les Ottolenghi's Form 4 filing for Stride, Inc. (LRN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Aug 2023, 16:37.
Les Ottolenghi - 18 Aug 2023 Form 4 Insider Report for Stride, Inc. (LRN)
- Reporting relationship
- CHIEF INFO. & TECH. OFFICER
- Issuer ticker
- LRN
- Reported as of
- 18 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Aug 2023, 16:37:28 UTC
- Prior SEC filing
- 15 Aug 2023
- Next SEC filing
- 09 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ John C. Grothaus, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Les Ottolenghi filed Form 4 for Stride, Inc. (LRN) on 22 Aug 2023.
Change
- Previous filing in this sequence was filed on 15 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LRN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +17,190
- Change %
- +35%
- Price
- $0.000000
- Shares after
- 66,907
- Date
- 18 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LRN
transaction
Derivative
Restricted Stock Right
Award
- Transaction value
- $0
- Shares
- +6,440
- Change %
- Price
- $0.000000
- Shares after
- 6,440
- Date
- 18 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,440
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares are restricted and vest semi-annually, with 20% vesting in the first year and 40% vesting in each of the next two years following the grant date.
Footnote F2
Represents an award of restricted stock rights, each of which represents a contingent right to receive one share of the Company's common stock. The restricted stock rights will vest based on the achievement of certain compound annual growth rates in the price of the Company's common stock between the award date and September 15, 2026, subject to earlier vesting in certain circumstances described in the applicable award agreement. The amount reported herein represents the threshold amount under the award.